Joanna Gromadzka-Ostrowska Selected Research

beta-Glucans

4/2024	Oat Beta-Glucan as a Metabolic Regulator in Early Stage of Colorectal Cancer-A Model Study on Azoxymethane-Treated Rats.
1/2022	Colon Expression of Chemokines and Their Receptors Depending on the Stage of Colitis and Oat Beta-Glucan Dietary Intervention-Crohn's Disease Model Study.
8/2021	Clinical Outcomes after Oat Beta-Glucans Dietary Treatment in Gastritis Patients.
4/2021	Anti-Inflammatory Activity of Oat Beta-Glucans in a Crohn's Disease Model: Time- and Molar Mass-Dependent Effects.
1/2021	Effects of Dietary Oat Beta-Glucans on Colon Apoptosis and Autophagy through TLRs and Dectin-1 Signaling Pathways-Crohn's Disease Model Study.
4/2020	Time-Dependent Indirect Antioxidative Effects of Oat Beta-Glucans on Peripheral Blood Parameters in the Animal Model of Colon Inflammation.
10/2019	Oral administration of oat beta-glucan preparations of different molecular weight results in regulation of genes connected with immune response in peripheral blood of rats with LPS-induced enteritis.
2/2015	The effect of low or high molecular weight oat beta-glucans on the inflammatory and oxidative stress status in the colon of rats with LPS-induced enteritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joanna Gromadzka-Ostrowska Research Topics

Disease

11	Inflammation (Inflammations) 01/2022 - 02/2008
6	Body Weight (Weight, Body) 12/2023 - 01/2013
5	Colitis 01/2022 - 10/2019
3	Carcinogenesis 04/2024 - 02/2021
3	Crohn Disease (Crohn's Disease) 01/2022 - 01/2021
3	Enteritis 10/2019 - 02/2015
2	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 11/2023
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 04/2024
1	Colonic Neoplasms (Colon Cancer) 04/2024
1	Cognitive Dysfunction 01/2022
1	Gastritis 08/2021
1	Prostatic Neoplasms (Prostate Cancer) 02/2021
1	Weight Gain 01/2021
1	Atherosclerotic Plaque (Atheroma) 11/2017
1	Lung Diseases (Lung Disease) 11/2017
1	Lung Neoplasms (Lung Cancer) 11/2017
1	Lung Injury 01/2017
1	Necrosis 01/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2013
1	Obesity 01/2013
1	Cystitis 02/2008
1	Neoplasms (Cancer) 01/2006

Drug/Important Bio-Agent (IBA)

8	(1-3)(1-4)- beta-glucanIBA 04/2024 - 10/2019
8	beta-GlucansIBA 04/2024 - 02/2015
6	AntioxidantsIBA 04/2024 - 06/2018
3	SteroidsIBA 12/2023 - 01/2006
2	AzoxymethaneIBA 04/2024 - 11/2023
2	ChemokinesIBA 01/2022 - 10/2019
2	SilverIBA 01/2022 - 01/2016
2	Interleukin-12 (IL 12)IBA 04/2021 - 02/2015
2	Sulfonic AcidsIBA 04/2021 - 04/2020
2	sym-trinitrobenzeneIBA 04/2021 - 04/2020
2	CytokinesIBA 04/2021 - 10/2019
2	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 02/2008
2	Hormones (Hormone)IBA 01/2021 - 01/2006
1	Biotin (Vitamin H)FDA Link 04/2024
1	Amino Acids FDA Link 04/2024
1	Folic Acid (Vitamin M)FDA LinkGeneric 04/2024
1	purineIBA 04/2024
1	Chemokine ReceptorsIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Bovine Serum AlbuminIBA 01/2022
1	IonsIBA 01/2022
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2022
1	Citric Acid (Citrate)FDA LinkGeneric 01/2022
1	Glutathione (Reduced Glutathione)IBA 08/2021
1	Dinoprostone (PGE2)FDA Link 04/2021
1	Polysaccharides (Glycans)IBA 04/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2021
1	Food IngredientsIBA 02/2021
1	Trans Fatty AcidsIBA 02/2021
1	MineralsIBA 01/2021
1	FertilizersIBA 01/2021
1	dectin 1IBA 01/2021
1	Caspase 3 (Caspase-3)IBA 01/2021
1	Ethanol (Ethyl Alcohol)IBA 01/2020
1	PolymersIBA 10/2019
1	EicosanoidsIBA 10/2019
1	Therapeutic UsesIBA 10/2019
1	Vehicle Emissions (Emissions, Vehicle)IBA 11/2017
1	Androgen Receptors (Androgen Receptor)IBA 01/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	Testosterone (Sustanon)FDA Link 01/2017
1	GlucansIBA 10/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	Interleukin-10 (Interleukin 10)IBA 02/2015
1	Thiobarbituric Acid Reactive SubstancesIBA 02/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2015
1	Triglycerides (Triacylglycerol)IBA 01/2013
1	LeptinIBA 01/2013
1	Ciprofloxacin (Cipro)FDA LinkGeneric 02/2008
1	FuraginIBA 02/2008
1	Interleukin-8 (Interleukin 8)IBA 02/2008
1	Nitrofurantoin (Macrodantin)FDA LinkGeneric 02/2008

Therapy/Procedure

1	Oral Administration 10/2019
1	Duration of Therapy 02/2008
1	Therapeutics 02/2008